- Home
- / Emisphere Technologies
Emisphere Technologies
Revenue
$1.2 M
FY, 2016
Emisphere Technologies Summary
Company Summary
- Overview
- Emisphere Technologies is a commercial-stage pharmaceutical and drug delivery company. It develops the Eligen drug delivery technology that facilitates oral absorption of biologics products. The Company also provides Eligen B12, an oral medical food that normalizes B12 level.
- Type
- Private
- Status
- Active
- Founded
- 1986
- HQ
- Roseland, NJ, US | view all locations
- Website
- https://www.emisphere.com/
- Cybersecurity rating
Table of Contents
Key People
Phil Nikolayuk, Director of Finance
David Gschneidner Ph, Vice President, Carrier R&D
John D. Harkey, Director
LocationsView all
1 location detected
Roseland, NJ HQ
United States
4 Becker Farm Rd
Emisphere Technologies Financials
Summary Financials
- Revenue (Q1, 2017)
- $222.0K
- Gross profit (Q1, 2017)
- $175.0K
- Net income (Q1, 2017)
- $6.1M
- Cash (Q1, 2017)
- $4.6M
- EBIT (Q1, 2017)
- ($1.1M)